Concepedia

Publication | Open Access

Long-Term Safety and Effectiveness of Adalimumab for Moderate to Severe Psoriasis: Results from 7-Year Interim Analysis of the ESPRIT Registry

46

Citations

17

References

2017

Year

References

YearCitations

Page 1